PlainRecalls
FDA Drug Moderate Class II Ongoing

Admelog, insulin lispro injection, 100 units/mL (U-100), 3mL multi-dose vial, Rx Only, Sanofi-Aventis U.S. LLC, Bridgewater, NJ 08807 A Sanofi Company. NDC 0024-5926-05

Reported: May 24, 2023 Initiated: April 11, 2023 #D-0575-2023

Product Description

Admelog, insulin lispro injection, 100 units/mL (U-100), 3mL multi-dose vial, Rx Only, Sanofi-Aventis U.S. LLC, Bridgewater, NJ 08807 A Sanofi Company. NDC 0024-5926-05

Reason for Recall

Lack of Assurance of Sterility: Malformed crimped collar seal

Details

Recalling Firm
Sanofi-Aventis U.S. LLC
Units Affected
51,325 vials
Distribution
Nationwide in the USA
Location
Bridgewater, NJ

Frequently Asked Questions

What product was recalled?
Admelog, insulin lispro injection, 100 units/mL (U-100), 3mL multi-dose vial, Rx Only, Sanofi-Aventis U.S. LLC, Bridgewater, NJ 08807 A Sanofi Company. NDC 0024-5926-05. Recalled by Sanofi-Aventis U.S. LLC. Units affected: 51,325 vials.
Why was this product recalled?
Lack of Assurance of Sterility: Malformed crimped collar seal
Which agency issued this recall?
This recall was issued by the FDA Drug on May 24, 2023. Severity: Moderate. Recall number: D-0575-2023.